Analyst Reco. Personalis, Inc.

Equities

PSNL

US71535D1063

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
1.3 ^USD	-5.80%		+8.33%	-38.10%

Mar. 26	Personalis, Inc. Announces Publication Validating Next Personal Test for Ultra-Sensitive MRD Detection and Cancer Treatment Response Monitoring	CI
Feb. 29	Needham Raises Price Target on Personalis to $3.50 From $2.30, Maintains Buy Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Needham Raises Price Target on Personalis to $3.50 From $2.30, Maintains Buy Rating	Feb. 29	MT
Needham Cuts Price Target on Personalis to $2.30 From $7, Maintains Buy Rating	Nov. 08	MT
HC Wainwright Adjusts Price Target on Personalis to $7.50 From $10, Maintains Buy Rating	23-08-09	MT
Needham Trims Price Target on Personalis to $7 From $8, Maintains Buy Rating	23-05-04	MT
Morgan Stanley Adjusts Price Target on Personalis to $5 From $11, Maintains Equal-Weight Rating	23-02-27	MT
HC Wainwright Trims Price Target on Personalis to $10 From $13, Maintains Buy Rating	23-02-24	MT
Needham Upgrades Personalis to Buy From Hold, Says Encouraged by Cost Reductions, Price Target is $8	23-02-06	MT
HC Wainwright Adjusts Personalis' Price Target to $13 From $26, Keeps Buy Rating	22-11-03	MT
Citigroup Adjusts Price Target on Personalis to $6 From $8, Maintains Buy Rating	22-11-03	MT
Citigroup Lowers Personalis' Price Target to $8 From $14, Maintains Buy Rating	22-08-04	MT
HC Wainwright Adjusts Personalis' Price Target to $26 From $30, Reiterates Buy Rating	22-08-04	MT
Citigroup Adjusts Personalis' Price Target to $14 from $18, Keeps Buy Rating	22-05-05	MT
HC Wainwright Adjusts Personalis' Price Target to $30 From $38, Reiterates Buy Rating	22-05-05	MT
HC Wainwright Adjusts Personalis Price Target to $38 From $50, Maintains Buy Rating	22-02-25	MT
Citigroup Adjusts Personalis Price Target to $18 From $30, Maintains Buy Rating	22-02-25	MT
Oppenheimer Adjusts Personalis' Price Target to $24 From $30, Maintains Outperform Rating	22-02-25	MT
Morgan Stanley Adjusts Personalis Price Target to $14 From $25, Maintains Equalweight Rating	22-02-15	MT
Morgan Stanley Downgrades Personalis to Equalweight from Overweight, Adjusts Price Target to $25 from $32	21-11-08	MT
Needham Downgrades Personalis to Hold From Buy on VA Program Uncertainty, Cash Burn, Model Change; $28 PT Removed	21-11-03	MT
PERSONALIS : BTIG Adjusts Personalis' Price Target to $30 from $35, Keeps Buy Rating	21-09-21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Personalis, Inc.

Equities

PSNL

US71535D1063

Analyst Reco.

Filters